87 results
6-K
EX-99.3
ADAP
Adaptimmune Therapeutics Plc
9 Oct 15
Adaptimmune announces New Research and Development Facility in Oxfordshire
12:00am
of Pennsylvania, and we have had roots in Philadelphia ever since. The location provides us with an environment that promotes strong business growth and innovation … employees with an environment that inspires innovation and collaboration.
“The Navy Yard’s vibrant campus presented a compelling option for Adaptimmune
8-K
EX-10.2
ADAP
Adaptimmune Therapeutics Plc
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
control environment for SOX compliance and control over the capital deployment of the Client
Lead the budget/financial plan preparation, review
8-K
EX-10.3
ADAP
Adaptimmune Therapeutics Plc
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
maintenance of an appropriate control environment for SOX compliance and control over the capital deployment of the Client
Lead the budget/financial
20-F
2015 FY
EX-4.10
ADAP
Adaptimmune Therapeutics Plc
13 Oct 15
Annual report (foreign)
12:00am
‘Environment’ includes air, man made structures and surface or substrata any surface water or ground water, any life form (including human) or eco … by contamination or pollution, the Environment or the presence of any substance harmful to the Environment present or occurring prior to this Lease otherwise
20-F
2015 FY
EX-4.8
ADAP
Adaptimmune Therapeutics Plc
13 Oct 15
Annual report (foreign)
12:00am
of this clause the expression ‘Environment’ includes air, man made structures and surface or substrata any surface water or ground water, any life … or Estate are affected by contamination or pollution, the Environment or the presence of any substance harmful to the Environment present or occurring
20-F
EX-4.9
jiv05p
13 Oct 15
Annual report (foreign)
12:00am
20-F
EX-4.11
cvj6khaq
13 Oct 15
Annual report (foreign)
12:00am
20-F
EX-4.15
38xv3hs6m
13 Oct 15
Annual report (foreign)
12:00am
8-K
EX-99.1
1t89y9n
9 May 18
Adaptimmune Reports First Quarter 2018 Financial Results and Business Update
7:39am
8-K
EX-99.1
eo04sq2
6 Nov 18
Adaptimmune Reports Third Quarter 2018 Financial Results and Business Update
7:36am
8-K
EX-99.2
fnm 9pfr8epumgzaf7
10 Apr 17
Adaptimmune Therapeutics plc Announces Closing of $42 Million Registered Direct Offering
12:00am
8-K
EX-14.1
02vb34jpeew8ibdc t56
24 Jul 17
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am
8-K
EX-10.2
taly6
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.4
ivn2u71v2nnyx6u7yon4
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-99.1
8ijgt7zxn
6 Jul 18
Departure of Directors or Certain Officers
5:00pm
8-K
EX-10.3
k1aue638d t5u4rgebj
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm